Sa1038 Comparison of IL28B Polymorphism and Viral Reduction Within Two Weeks for Predicting Sustained Virological Response to Low-Dose PEG-Interferon Alpha 2A Plus Ribavirin Therapy for High-Risk Patients With Genotype 1b and a High Hepatitis C Viral Load...